Industry
Insilico, which uses AI to accelerate drug discovery, says early data shows rentosertib, a drug whose structure was generated with AI's help, could slow aging (Cade Metz/New York Times)
Cade Metz / New York Times: Insilico, which uses AI to accelerate drug discovery, says early data shows rentosertib, a drug whose structure was generated with AI's help, could slow aging — Artificial
Cade Metz / New York Times: Insilico, which uses AI to accelerate drug discovery, says early data shows rentosertib, a drug whose structure was generated with AI's help, could slow aging — Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition.
Related
- Sources: Lila Sciences, which uses AI tools to speed up the rate of scientific discovery, is in talks to raise a 2B Series B at an expected valuation of ~8.5B (Bloomberg)
- Triomics, which is building an AI-powered platform to help oncologists automate data-heavy tasks, raised a 22M Series B, following a 15M Series A in 2024 (Marina Temkin/TechCrunch)
Source: Techmeme | 2026-09-07